The acid-sensing ion channel (ASIC) has emerged as a novel type of ion channel that is activated by extracellular protons as well as nonproton ligands. Advances in ASIC research have resolved its multifaceted structural and functional properties, including its widespread distribution, polymodal activation, and activity-dependent regulation of its expression. All of these properties promote a better understanding of the roles played by pH dynamics as well as damage-related signals through activation of ASICs in pain and anxiety. Importantly, even more studies have provided strong evidence supporting the effectiveness of targeting ASICs with pharmacological agents or gene knockdown for treating pain and anxiety. Here we review the contribution of ASICs at the peripheral and central levels to the development of acute pain, inflammatory pain, neuropathic pain, and anxiety-related disorders, as well as their potential underlying mechanisms. Accumulating evidence suggests that ASICs represent a novel class of promising targets for developing effective therapies for pain and anxiety.
INTRODUCTION
Pain is defined as an unpleasant sensory and emotional experience associated with actual or potential tissue damage [1] , which encompasses nociceptive pain, inflammatory pain, and neuropathic pain [2] . While nociceptive pain is caused by stimulation of peripheral nerve fibers that respond only to stimuli approaching or exceeding harmful intensity, inflammatory pain is associated with tissue damage and the infiltration of immune cells [3] . Neuropathic pain is a disease state caused by damage to the nervous system or by its abnormal function [3] . Related to but different from pain, anxiety is a psychological and physiological state characterized by somatic, emotional, cognitive, and behavioral components with the displeasing feeling of fear and concern [4] . Both pain and anxiety are influenced by a vast number of chemical factors including tissue acidosis, necessitating acid sensors to mediate proton-dependent neuronal signaling [5] to shape the physiological response at different levels.
One emerging class of membrane receptors that directly sense extracellular acidosis is the acid-sensing ion channels (ASICs) [6] [7] [8] , members of the sodium-selective cation channels belonging to the epithelial sodium channel/degenerin (ENaC/DEG) family [9] . To date, functional cloning of ASIC subunits has demonstrated three genes (ASIC1, 2, and 3) that yield at least five ASIC isoforms (ASIC1a, 1b, 2a, 2b, and 3; Fig. 1A ). These isoforms can associate in various combinations forming channels that differ in pH sensitivity, ion selectivity, as well as activation and desensitization kinetics [6] [7] [8] . Additional ASIC subunits [i.e. ASIC4 and brain-liverintestine amiloride-sensitive Na + channel (BLINaC)] have not been shown to produce or modify H + -evoked currents [10, 11] , suggesting a distinct functional class of channels/receptors or complexes that incorporate only these subunits. There is a relative distribution specificity of various ASIC subtypes between the peripheral and central nervous systems [7] . While ASIC1b and 3 are primarily expressed in sensory neurons, ASIC1a, 2a, and 2b are expressed in both the peripheral and central nervous systems (Fig. 1B) . In addition to their widespread distribution in neurons, ASICs are also expressed in non-neuronal cells [12] . In accordance with the specific distribution profiles, ASIC3 mainly participates in multimodal sensory perception [12, 13] , including nociception [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] , mechanosensation [26] [27] [28] [29] , chemosensation [30] [31] [32] [33] [34] [35] [36] [37] , and other modalities of sensory perception [38] [39] [40] [41] [42] . By contrast, ASIC1a is believed to perform diverse roles in the central nervous system [13] implicating neuronal excitability [43] [44] [45] , synaptic transmission [46] [47] [48] [49] , fear learning and memory [50] [51] [52] [53] [54] [55] , seizure termination [56] , ischemic neuronal death [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] , central pain sensitization [67] [68] [69] [70] [71] [72] [73] , drug addiction [74, 75] , and the development of many neurodegenerative diseases [76, 77] .
Functional ASICs are trimeric channel complexes proposed to share an overall structural similarity with other members of the ENaC/DEG family [9] . More than one crystal structure [78] [79] [80] [81] [82] of ASIC1a channels has been resolved recently, which gives rise to a profile of these receptors. The trimeric ASIC complexes form a chalice-like architecture. Each subunit is composed of a large extracellular region, two transmembrane domains, and cytosolic N and C termini (Fig. 1A) . The large extracellular domains are responsible for sensing the concentration of extracellular protons and nonproton ligands as well. Indeed, endogenous spermine ( Fig. 2A) was shown to sensitize acid-induced ASIC1a activation and to exacerbate ischemic neuronal injury [58] . In addition, synthetic compounds such as 2-guanidine-4-methylquinazoline (GMQ) [83] , an endogenous ligand agmatine together with its structural analog arcaine [84] (Fig. 2A) , can cause persistent activation of ASIC3 at normal pH. By using GMQ as a probe and combining mutagenesis and covalent modification analysis, we identified a novel nonproton ligand sensing domain [83, 85, 86] located in the extracellular region of the ASIC3. Moreover, amiloride, a well-known ASIC blocker, also paradoxically activates ASIC3 channels at the neutral pH, dependent on this domain [86] . Notably, the inflammatory mediator serotonin (5-HT) was demonstrated to facilitate peripheral pain sensitivity in a manner that depends on the nonproton ligand sensing domain of the ASIC3 channel [87] . Coincidently, a more recent report [88] showed that a Texas coral snake (Micrurus tener tener) toxin, MitTx, in a heteromeric manner (MitTx-/ ; Fig. 2B ), directly activates ASIC1a channels to elicit robust pain-related behaviors in mice, further supporting the existence of ligands beyond acid for ASICs [8] . Structurally, MitTx-/ forms extensive interactions with the wrist, palm, and thumb domains, supporting the notion that these domains play dominant roles in activation of the ion channel [82] . Furthermore, alkaline pH can open a human ASIC3 transcript in a manner distinct from acid-induced channel activation [89] . Thus, ASICs are capable of dynamically adapting their activity to sense the chemistry of the extracellular environment. Together, these structural and functional properties of ASICs in conjunction with their expression profiles make them suitable for participating in various sensation and transmission processes at different levels and across diverse forms of pain and anxiety.
ASIC IN PERIPHERAL NOCICEPTION ASIC3

Distribution, Sensitization, and Activation
In principle, each type of peripheral ASIC can be activated to different degrees by acidosis, physiologically and pathologically.
However, studies of peripheral ASICs in nociception have focused primarily on the ASIC3 subtype because of its multiple properties suitable for peripheral nociception [12] . First, ASIC3 is widely expressed at high levels in the membranes of peripheral sensory neurons and non-neuronal tissues [90] [91] [92] , making it an ideal antenna to detect acidosis and related nociceptive stimuli [24] . Second, inflammatory signals associated with tissue damage such as proinflammatory mediators [i.e. nerve growth factor, 5-HT, interleukin-1, bradykinin, and brain-derived neurotrophic factor (BDNF)] enhance ASIC3 transcription [93, 94] , which may act as a sensitization mechanism mediating the action of ASIC3 in inflammatory pain. Third, ASIC3 mRNA and protein levels are increased by plantar incision (a model of postoperative pain) 24 h after surgery [72] , raising a potential mechanism of peripheral sensitization [83] ; agmatine, an endogenous activator of ASIC3 channels [83, 84] ; arcaine, a structural analog of agmatine and an activator of ASIC3 channels [83, 84] ; amiloride, a common blocker of the ENaC/DEG family and an activator of ASIC3 channels [86] ; 5-HT, a proinflammatory mediator that significantly enhances the sustained component of ASIC3 current and facilitates peripheral pain sensitivity [87] ; spermine, an endogenous polyamine that sensitizes ASIC1a activation to acidosis and exacerbates ischemic neuronal injury [58] . (B) Shown are the crystal structures of PcTX1 (PDB code: 1LMM, [118] ), a specific inhibitor for homomeric ASIC1a and heteromeric ASIC1a-2b channels; APETx2 (PDB code: 1WXN, [110] ), a specific inhibitor for ASIC3-containing channels; mambalgin-2 (PDB code: 2MFA, [120] ), a specific inhibitor for homomeric ASIC1a and heteromeric ASIC1a-2a as well as ASIC1a-2b channels; MitTx-/ (PDB code: 4NTW, [82] ), an activator for ASICs. For (B), figures were generated with PyMol.
underlying ASIC3 participation in postoperative pain and presumably other forms of neuropathic pain as well. Fourth, ASIC3 is the most pH-sensitive type among the different subunits and carries multiple unique features distinct from other ASIC subtypes [12] . In particular, in response to mild acidosis (pH 7.3-6.7), the ASIC3 channel opens in a largely non-desensitizing manner and gives rise to a characteristic "window current" resulting from the collective effects of steady-state activation and inactivation [24, 30] . In addition, the ASIC3 channel responds to a group of compounds including synthetic GMQ [83] and endogenous agmatine [84] (Fig. 2A) , in a manner that is highly sensitive to inflammatory signals [24] such as mild acidosis [30, 95] , hyperosmolarity [96] , arachidonic acid [97] , lactate [98] , reduced extracellular Ca 2+ [99] , and 5-HT [87] . This provides strong evidence that ASIC3 can act as a polymodal integrating sensor [12] of acidic and inflammatory pain [24] . ASIC3 is the only exception to the common features shared by most ASIC members that protons trigger a rapidly desensitizing transient current. It mediates an extra sustained current that does not fully desensitize [90] [91] [92] , despite persisting extracellular acidosis. Moreover, this sustained component is greatly enhanced when the channel is activated in the presence of the inflammatory mediator 5-HT [87] and the Phe-Met-Arg-Phe-amide and related neuropeptides [100] . Taken together, these properties promote a view that ASIC3 channels act as a natural sensor for inflammatory or neuropathic pain associated with acidosis and beyond.
Behavioral Characterization
Studying gene-targeted mice is undoubtedly helpful in clarifying roles of ASICs in nociception. To date, at least four lines of ASIC3 knockout mice [14, 25, 26, 101] , and one type of transgenic mouse that expresses a dominant-negative form of the ASIC3 subunit [102] have been generated and characterized. Studies on these mice revealed the roles that are mainly related to pain sensation, including cutaneous and muscle nociception, gastrointestinal mechanosensation [103, 104] , and heart and lung nociception. In addition, ASIC3 knockout mice demonstrate reduced anxiety [105] and enhanced insulin sensitivity [106] , arguing that targeting ASIC3 might have additional benefits to synergize with analgesics [107] . For details on the deficiency of ASIC3 knockout mice, please refer to other reviews [12, 107, 108] .
As a complementary approach to exclude the possible effects of gene compensation in ASIC3 knockout mice, pharmacological intervention using selective inhibitors, as well as acute gene knockdown, further strengthen the notion of the channel activation under multiple forms of the pain process. APETx2, a 42-amino acid peptide ( Fig. 2B ) isolated from the sea anemone Anthopleura elegantissima [109, 110] specifically inhibits ASIC3-containing channels [111] . By using APETx2 and in vivo knockdown of ASIC3 with a specific small interfering RNA (siRNA), Deval et al. [24] reported that inhibition and reduction of ASIC3 produce potent analgesic effects against primary inflammatory hyperalgesia in rats. Dependent on its properties related to activation and sensitization as previously described, peripheral ASIC3 channels contribute to primary hyperalgesia by acting as sensors and integrators of acidic and inflammatory signals [12, 84] . Based on the observation that 5-HT specifically enhances the proton-evoked sustained activation of ASIC3 channels dependent on the nonproton ligand sensing domain, Wang et al. [87] demonstrated that coapplication of 5-HT and acid significantly increased pain-related behaviors. This effect was largely attenuated in ASIC3 knockout mice, and inhibited by the nonselective ASIC inhibitor, amiloride, but not by 5-HT receptor inhibitors. Together, these later data identify ASIC3 channels as an unexpected molecular target for acute actions of 5-HT and reveal an important role of ASIC3 channels in regulating inflammatory pain via coincident detection of extracellular protons and inflammatory mediators [12, 84] .
By using pharmacological and genetic approaches, Deval et al also demonstrated a significant role of ASIC3 in a rat model of postoperative pain. They reported that inhibition or reduction of this channel led to a significant decrease in spontaneous, thermal, and postural pain behaviors [72] . In summary, these results clearly demonstrate the substantial roles of ASIC3 as peripheral nociceptors in inflammatory pain and neuropathic pain.
ASIC1
Both ASIC1a and 1b channels are protein products of the single ASIC1 gene through alternative splicing [6, 112, 113] . In contrast to the exclusive expression of ASIC1b in peripheral neurons, ASIC1a channels are expressed in both peripheral and central neurons (Fig.  1B) . ASIC1a channels have long been considered as acid sensors in the central nervous system and are required for acid-evoked currents in central neurons [46] , where they contribute to neuronal excitability [43] [44] [45] , synaptic transmission and plasticity [46, 47, 49] , and dendritic spine development [114] . However, the role of peripheral ASIC1a channels remains to be established. The physiological roles of ASIC1a in sensory neurons was partially implicated by a study showing that activity-dependent expression of ASIC1a is facilitated by inflammatory signals [93, 94] , but downregulated in neuropathic pain models [115] .
Behavioral studies on the peripheral involvement of ASIC1a in pain sensation using the gene-targeted mice gave an indefinite picture. The ASIC1a null mice did not differ from wild-type (WT) animals either in the functioning of cutaneous mechanoreceptors [116] or in mechanical hyperalgesia produced by repeated intramuscular acid injections [18] . In contrast to the genetic results, a recent study [88] revealed a clearer role of ASIC1a channels in chemical pain. They first characterized a heteromeric snake toxin MitTx-/ (Fig. 2B) isolated from the Texas coral snake that acts as a persistent and potent agonist for ASIC1a channels with equal or even greater efficacy when compared with acidic pH. Using this novel agent, the researchers characterized robust activation of ASIC1a channels in ASIC1a-expressing dorsal root ganglion (DRG) neurons in addition to the subsequent pain-related licking behaviors following administration of this toxin in WT but not ASIC1a knockout mice [88] . These results suggest an unexpected contribution of peripheral ASIC1a channels to nociception, raising the possibility that peripheral ASIC1a channels function as coincidence detectors for extracellular protons and nonproton activators such as toxins to elicit pain response.
The peripheral contribution of ASIC1a and ASIC1b was further advanced using peptides targeting these channels. PcTx1 (Fig. 2B) , a peptide isolated from the venoms of the spider Psalmopoeus cambridgei [117, 118] , has been shown to specifically inhibit homomeric ASIC1a and heteromeric ASIC1a-2b channels [119] . Furthermore, a new class of three-finger peptides from the black mamba, mambalgins (Fig. 2B) , has recently been identified to produce strong inhibition on homomeric ASIC1a, and heteromeric ASIC1a-2a in addition to ASIC1a-2b channels [73, 120] . Notably, peripheral administration of mambalgin-1, but not PcTX1, produces a potent analgesic effect against nociceptive pain and prevents inflammatory hyperalgesia [73] . Interestingly, mambalgin-1 still evokes significant peripheral analgesic effects in ASIC1a knockout mice, arguing for a negligible contribution of peripheral ASIC1a channels to nociception [73] . Moreover, silencing the ASIC1b subunit in nociceptors of ASIC1a knockout mice mimicked the analgesic effect of peripheral mambalgin-1 injection on both acute pain and inflammatory hyperalgesia [73] , supporting the specific participation of ASIC1b, but not ASIC1a channels, in the peripheral effect of mambalgin-1. The significance of ASIC1b in peripheral nociception was further supported by the identification of an unexpected Ca 2+ -permeable human ASIC1 transcript variant (comparable to ASIC1b with little Ca 2+ permeability in rats) [113] . This variant also displays a small acid-evoked sustained current (distinct from that in rats), suggesting a more striking contribution to aciddependent pain sensation in humans [121, 122] . Considering the exclusive distribution of ASIC1b in sensory but not central neurons, we believe that ASIC1b likely plays a currently underestimated role in peripheral nociception in rodents and humans.
ASIC2a/2b
Studies with ASIC2 gene deletion mice showed that these mice indeed have defects in particular forms of somatic and visceral mechanosensation [101, [123] [124] [125] , but have normal responses to noxious mechanical stimulation. Owing to the lack of specific pharmacological tools to manipulate ASIC2 function, the exact roles of these types of ion channels in the peripheral pain sensation are not clear.
ASIC IN SPINAL NOCICEPTIVE PLASTICITY Characterization of ASIC Subunits in the Spinal Dorsal Horn Molecular Evidence
The spinal dorsal horn (SDH), as the first relay station of sensory processing plays an indispensable role in the integration, transmission, and amplification of pain information. The mRNAs of ASIC1a, 2a, and 2b are detected in SDH neurons [67] , and the protein of ASIC1a and 2a subunits are shown by Western blotting [67] and immunohistochemistry [68] . Interestingly, the expression of ASIC1a is restricted to SDH neurons, but not the afferent DRG nerve terminals [68] . Whether any other ASIC subunits distributed to the presynaptic terminus of afferent synapses to the SDH (Fig.  1B) , and the potential physiological relevance of this [47] , remain to be established in the future.
Electrophysiological Characterization
Electrophysiological and pharmacological profiles of ASICs in dorsal spinal cord in the rat and mouse have been intensively examined in acutely dissociated and cultured SDH neurons. Based on the pH values for threshold and half-maximum activation, desensitization rate, ion selectivity, Ca 2+ and Zn 2+ sensitivity, and PcTX1 sensitivity, homomeric ASIC1a and heteromeric ASIC1a-2b channels were believed to be responsible for the acid-induced current in these neurons in rats [67] . In contrast, from studies using ASIC2 knockout mice and PcTX1 as the pharmacological tool, ASIC1a and 2a were found to be the most predominant subunits of SDH in mice [71] . Although there is marked variance among different species, ASIC1a is clearly expressed in SDH neurons of rodents. For ASIC1a or ASIC2a/b subunits in the SDH, it remains an open question as to whether ASICs play an antagonistic or synergetic role in excitatory neurons and inhibitory interneurons [43, 56] of the SDH.
Behavioral Characterization Acute Pain
As described earlier, ASIC1a is distributed in both peripheral and central neurons. Thus, the nociception might be affected and compensated at multiple levels in ASIC1a knockout mice. To understand the specific roles of spinal ASICs in pain sensation, intrathecal injection of specific pharmacological tools (i.e. PcTX1 or mambalgin-1) and specific siRNAs targeting different ASIC subunits is needed.
Intrathecal injection in naïve rats of either ASIC1a antisense oligonucleotide or PcTX1, the inhibitor of homomeric ASIC1a or heteromeric ASIC1a-2b channels, does not affect either acute thermal or mechanical sensitivity [68] . Moreover, intrathecal injection of PcTX1 immediately after formalin administration had no effect on the early phase, but reduced the secondary phase of formalininduced pain behavior [68] . These results suggest homomeric ASIC1a and heteromeric ASIC1a-2b channels play an insignificant role in acute pain sensation in rats.
Meanwhile, similar intrathecal treatment in mice yields a robust acute analgesia against thermal and chemical (formalin)-induced pain. Interestingly, the potent analgesic effects of PcTX1 are mediated in large part by activation of the endogenous enkephalin pathway [70, 73] , which leads to an increased level of met-enkephalin in the cerebrospinal fluid (Fig. 3) . The analgesic effects of PcTX1 are suppressed in the presence of antagonists of the μ and -opioid receptors and are lost in mice deficient for the preproenkephalin gene [70] . The underlying mechanism is still unclear, but it probably involves the activation of ASIC1a in spinal inhibitory interneurons [43, 56] (Fig. 3) , an interesting hypothesis that needs to be tested in the future.
By contrast, intrathecal application of mambalgin-1 which targets homomeric ASIC1a and heteromeric ASIC1a-2a in addition to ASIC1a-2b channels gives rise to a robust analgesia in WT but not ASIC1a knockout mice [73] . As supportive evidence, intrathecal knockdown of ASIC2a reduces the analgesia effects of mambalgin-1, suggesting the involvement of the ASIC2a subunit in acute pain sensation in mice. Thus heteromeric ASIC1a-2a channels in SDH are likely responsible for the mambalgin-1-inhibited pain [71] . In contrast to the effect of PcTX1, the effect of mambalgin-1 is resistant to the opioid receptor antagonist naloxone and largely independent of the enkephalin pathway [73] . Collectively, these findings suggest two distinct pathways involving spinal ASIC mediation of pain transmission (Fig. 3) . While ASIC1a and ASIC1a-2b channels point to a tonic inhibition of the enkephalin pathway, heteromeric ASIC1a-2a channels mediate an opioid-independent mechanism (Fig. 3) . However, the exact physiological roles of ASIC1a in the spinal circuit are poorly understood, pending more in-depth examination in the future.
Inflammatory Pain
In rats, blocking ASIC1a and ASIC1a-2b channels by intrathecal injection of PcTX1 and suppression of ASIC1a expression by its antisense oligonucleotide in the SDH significantly attenuated both thermal and mechanical hypersensitivity induced by peripheral inflammation with the standard complete Freund's adjuvant (CFA) treatment [68] . Moreover, intrathecal injection of PcTX1, immediately after formalin administration, significantly reduced the secondary phase without affecting the early phase of formalin-induced pain behavior [68] , implying a specific role of spinal ASIC1a in inflammatory, but not acute, pain signaling in rats.
Similar to the analgesia effects of PcTX1 in the rats, blocking spinal ASIC1a-2a heteromeric channels by mambalgin-1 suppressed inflammatory heat hyperalgesia, and produced a strong analgesia, as evaluated in the paw-flick test, after intraplantar injection of carrageenan, and drastically decreased inflammatory pain assessed in the formalin test in mice [73] . Together, ASIC1a-containing channels are crucial for pain transmission in the SDH of rodents.
Neuropathic Pain
Consistent with the significant roles of spinal ASIC1a in acute and inflammatory pain, spinal delivery of PcTx1 reduces hyperalgesia in an enkephalin-dependent manner in mice (Fig. 3) with a chronic constriction injury of the sciatic nerve [70] , which is a model of neuropathic pain. Hence, an ASIC antagonist might represent a novel painkiller for neuropathic pain. As the mechanistic details underlying these observations remain largely unknown, further research is needed to define specific types of neuropathic pain that might be alleviated effectively by ASIC blockade.
ASICs in Spinal Synaptic Plasticity
The importance of spinal ASICs at the behavioral level could be explained by their involvement in synaptic plasticity at the cellular level [68, 69] . Nociceptive hypersensitivity and chronic pain probably involve cellular mechanisms similar to those underlying learning and memory [126] [127] [128] [129] [130] . The cellular roles of ASIC1a has been suggested in forebrain long-term potentiation (LTP) of synaptic transmission [46, 49] and regulation of synaptic strength associated with activity-dependent learning [46, 50, 51, 53, 54, 75] . Analogously, the activation of ASIC1a is required for C-fiber-induced "wind-up" and CFA-induced hypersensitivity of SDH nociceptive neurons, two forms of central sensitization of pain transmission [68, 69] . Considering the fact that C-fiber discharge rates required for inducing "wind-up" can induce LTP at C-fiber synapses in the SDH [131, 132] , we suggest that ASIC1a-dependent synaptic plasticity [68] is likely to participate in the modification of spinal processing of nociceptive signals and the development of inflammatory pain hypersensitivity.
The roles of ASIC1a in synapse physiology were strengthened by recent evidence supporting the notion that protons act as neurotransmitters at vestibular hair cell-calyx afferent synapses [133] and in the lateral amygdala [49] in addition to the nucleus accumbens [75] . As a proton receptor, ASIC1a in lateral amygdala pyramidal neurons can be activated by transient reduction of extracellular pH upon presynaptic stimulation [49] , an unexpected mechanism that gives rise to a significant excitatory postsynaptic current independent on the activation of glutamate receptors (Fig. 4A) . Notably, synaptic plasticity in the lateral amygdala requires both cleft acidification and ASIC1a activation associated with synaptic transmission [49] , arguing a necessity of synaptic ASIC1a action (Fig. 4A) for amygdala-dependent learning and memory. However, whether ASIC1a channels are indeed involved in pain transmission in the SDH (Fig. 4A) remains to be tested in the future.
ASIC1a is activated in response to extracellular acidosis and is permeable to Na + and Ca 2+ [6] , causing neuronal depolarization to trigger an action potential, and to release the Mg 2+ blockade of Nmethyl-D-aspartate (NMDA) receptors [46] (Fig. 4A) in SDH neurons, and promote the Ca 2+ -dependent signaling cascades (Fig. 4B) . These processes may facilitate the glutamate receptor-dependent synaptic plasticity and central sensitization underlying nociceptive hypersensitivity related to peripheral inflammation or nerve damages. In addition, synaptic activation of ASIC1a probably occurs more readily under pathological conditions, a process that in turn benefits to sustain the spinal synaptic activity that is probably related to chronic pain behaviors. First, synaptic activity in the SDH is enhanced under the situations associated with inflammatory or neuropathic pain [126] [127] [128] [129] [130] . Likewise, the extent of cleft acidification is presumably augmented and more easily activates ASICs. Second, the numbers of surface ASIC1a available for activation in the SDH are increased under the peripheral inflammatory models [67, 68] . Third, ASIC1a activity may be modulated via unidentified intracellular signaling cascades such as Ca 2+ /calmodulin-dependent protein kinase II (CaMKII)-dependent phosphorylation following activation of NMDA receptors [57] (Fig. 4A) in the SDH.
Consistent with the idea of synaptic ASIC1a activation under chronic pain conditions, forward trafficking of ASIC1a channels has been recently demonstrated to be required for sustaining the spinal BDNF-induced mechanical hyperalgesia [134] . Intrathecal injection of exogenous BDNF caused hyperalgesic responses in mice. However, in ASIC1a knockout mice, the mechanical hyperalgesia started to attenuate at 30 min and was diminished at 3 h after BDNF administration [134] . At the cellular level, BDNF and its receptor, tropomyosin-related kinase B (TrkB) significantly enhanced forward trafficking and increased surface ASIC1a expression via the phosphoinositide 3-kinase (PI3K)-protein kinase B (PKB/Akt) cascade and phosphorylation of cytoplasmic residue Ser-25 of ASIC1a [134] . As BDNF signaling and ASIC1a sensitization happens simultaneously in sustaining inflammatory hyperalgesia, the dynamic interplay between BDNF and ASIC1a probably accounts for the synaptic plasticity of the SDH. As the supporting evidence, the N-terminal region of ASIC1a encompassing Ser-25 is essential for BDNF-mediated hypersensitivity of SDH neurons, and an interfering peptide against this functional motif abolished the BDNF-mediated hypersensitivity of capsaicin-induced central mechanical hyperalgesia [134] . Together, the spinal ASIC1a trafficking and related synaptic plasticity play a prominent role in regulating pain sensation and transmission.
ASIC IN SUPRASPINAL PLASTICITY Higher Levels of Pain Modulation
ASIC1a and ASIC2 are located in the SDH [68, 71] where painrelated plasticity occurs and through which pain signals are trans- Fig. (3) . Pathways involving spinal ASIC action in pain transmission. Behavioral studies [52] have shown that intrathecal injection of PcTX1, an inhibitor targeting homomeric ASIC1a and heteromeric ASIC1a-2b channels, produces pain relief by activation of the endogenous enkephalin pathway. It is inferred that these two types of ASICs, probably in interneurons, exert a tonically inhibitory effects on endogenous enkephalin pathways for pain modulation. Based on the findings [73] that mambalgins (through inhibition of ASIC1a, ASIC1a-2a, and ASIC1a-2b channel types) induce a naloxone-independent analgesic effect, an assumption is drawn that a heteromeric ASIC1a-2a configuration (probably expressed by excitatory neurons) mediates an opioid-independent pathway for pain modulation. See the text for more details.
mitted to the brain. In the brain, ASIC1a is enriched in areas with strong excitatory synaptic input [50] , such as the amygdala, cingulate cortex, and cerebellar cortex, critical regions for pain processing. Moreover, ASIC1a is also abundantly expressed in both the ventral and dorsal regions of the periaqueductal gray matter [50, 52] , which are important sites for pain modulation. The abundant expression of ASIC1a in multiple regions associated with pain calls for more comprehensive examination on its precise contribution to pain modulation.
As Ronald Melzack and Kenneth Casey stated in 1968, pain is in terms of its three dimensions [135] , sensory-discriminative, affective-motivational, and cognitive-evaluative. Indeed, pain intensity and unpleasantness are not simply determined by the magnitude of the painful stimulus, but are also influenced by the higher cognitive activities. In view of the fact that ASIC1a channels have been implicated in fear learning and memory [50] [51] [52] [53] [54] [55] and other forms of cognitive function [46, 74, 75] , we speculate a higher-level modulation of unpleasantness and cognition associated with pain by ASIC1a through as yet unidentified mechanisms. To improve our understanding of the exact roles of supraspinal ASICs in pain sensation and transmission, behavioral studies under region-specific application of pharmacological tools (Fig. 2B) or genetic manipulation are needed. Neuron type-specific roles of ASICs should also be considered in the future [43] .
ASICs in Anxiety-Related Behaviors
Consistent with the speculation of supraspinal ASIC1a in pain modulation, ASIC1a has also been implicated in anxiety-related behaviors. First, ASIC1a is abundant in regions critical for anxiety [50] and responses to aversive stimuli [136] , including the basolateral amygdala, bed nucleus of the stria terminalis (BNST) [137] , cingulate cortex, hypothalamus, and periaqueductal gray matter [50, 52] . Second, ASIC1a knockout mice showed strong deficits in anxiety-related behaviors. A reduced cue and contextual fear conditioning [50] , in addition to an unconditioned fear response to the predator odor trimethylthiazoline (TMT), as well as to acoustic startle, and fear of open spaces [52] , were all decreased in ASIC1a knockout mice. Third, overexpression of ASIC1a increased contextual fear conditioning [51] . Fourth, restoring ASIC1a expression in the basolateral amygdala of ASIC1a knockout mice reversed their deficits in contextual fear memory, but not the freezing deficit observed immediately following foot-shock nor the deficit in the unconditioned fear response to TMT [53] . Fifth, inhaling carbon dioxide (CO 2 ) leading to reduction of the extracellular pH in the amygdala [54] and BNST [137] evoked a substantial fear behavior in WT but not ASIC1a knockout mice. Significantly, localized ASIC1a expression in the amygdala or BNST rescued the CO 2 -induced fear deficit of ASIC1a null animals. Sixth, pharmacological antagonism of ASIC1a reduces the above fear-and anxiety-related behaviors in mice. Injection of PcTx1 into the amygdala attenuates the TMTevoked fear response [52] and impairs the CO 2 -evoked freezing behaviors [54] . Finally, genome-wide studies have suggested ASIC1a as a candidate susceptive gene for panic disorder in humans [138, 139] . Collectively, central ASIC1a channels play a significant role in modulation of anxiety-related behaviors and represent a promising target for anxiety-related disorders, in addition to pain.
The molecular mechanisms by which ASICs mediate anxiety remain to be established. Specially, whether anxiety is accompanied by a reduction of extracellular pH that is sufficient for activation of ASIC1a channels, represents an interesting idea, which has not been established yet. A pH-sensitive magnetic resonance imaging study demonstrated a pH dysregulation that occurred in human subjects with panic disorder [140] , a type of anxiety disorder that is characterized by unexpected and repeated episodes of intense fear accompanied by physical symptoms. These results together with animal studies have shown that CO 2 -mediated panic behavior depends on chemosensing of acidosis in the amygdala [54] and BNST [137] via ASIC1a, which strengthens the possibility that targeting these channels may have therapeutic potentials for panic disorders. In another model of anxiety-related disorders that are caused by repeated social defeat, peripheral myeloid cells are primed and central microglia are activated to induce anxiety-like behavior [141] . It is possible, but highly speculative, the recruited monocytes from bone marrow to brain probably provide the source of protons to regulate ASIC1a activity and promote anxiety-like behavior. Consistent with the speculation of ASIC1a dysfunction associated with pH disturbance in anxiety, in vivo activation of ASIC1a in the basolateral amygdala was shown to suppress anxiety-like behavior in rats through enhancement of inhibition [142] . Thus, ASIC1a might possess an inhibitory and anxiolytic function; a promising proposal that needs additional supporting studies on the underlying mechanisms.
CONCLUDING REMARKS
While many exciting therapeutic implications for the treatment of pain and anxiety by targeting ASICs have been delineated in the present review, several substantial achievements in the ASIC field must be accomplished before they can be applied to the clinical setting.
First, species differences of ASICs should be preferentially considered. For example, human but not rodent ASIC1b channels [112, 113] are permeable to Ca 2+ , and present a significant sustained current in response to acid, suggesting a more significant role of ASIC1b channels in humans than in rodents. Moreover, it has been suggested that inhibition of peripheral ASIC1b channels in mice accounts for part of the analgesic effect of mambalgin-1 [73] . However, the exact roles of ASIC1b remain unclear. Mechanistically, generation and characterization of ASIC1b knockout mice in the future would shed light on its physiological role in pain sensation [46] .
Second, the roles of brain ASIC1a in higher-level modulation of pain remain unclear. Nevertheless, ASIC1a has been implicated in anxiety-related disorders, for which the cellular and circuit mechanisms are largely unknown. In this regard, pharmacotherapy targeting ASIC1a channels in humans [121, 122] should follow the complete identification of precise physiological significance and their underlying mechanisms for ASIC1a-dependent cognitive effects.
Finally, the most important and urgent challenge for analgesia by targeting this type of channel remains the development of more specific and effective pharmaceutical agents. Although a group of selective peptide inhibitors for ASICs such as APETx2, mambalgin-1, and PcTX1 (Fig. 2) are available, their safety and delivery must be established in the future. Furthermore, researchers have identified a series of potent and specific compounds that act as ASIC antagonists [143] [144] [145] [146] [147] , but as yet, none are suitable for clinical use. Along with the development of pharmacological agents directly targeting ASICs, alternative strategies might be considered by targeting pain or anxiety-related signals (i.e. BDNF pathway) known to potentiate the activity of these channels [134] . In summary, ASICs are promising therapeutic targets for pain and anxiety, but more knowledge on the channel structure, function, and regulation, in addition to pharmacological tools and agents to manipulate channel function, need to be learned by diverse approaches [148] to translate this promise into reality.
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